Terbinafine Dosing for Recurrent Tinea Corporis
For an adult with recurrent tinea corporis and normal liver function, use oral terbinafine 250 mg once daily for 2-4 weeks, with consideration for extending therapy to 4-6 weeks in recurrent cases.
Standard Dosing Approach
The FDA-approved dose for adults (>40 kg body weight) is 250 mg once daily 1. While the available guidelines primarily address tinea capitis, they consistently recommend this same 250 mg daily dose for adults 2.
Duration Considerations for Recurrent Disease
- Initial treatment: 2-4 weeks is standard for tinea corporis 3, 4
- Recurrent cases: Consider extending to 4-6 weeks given the recurrent nature
- Treatment failure protocol: If clinical improvement occurs but mycology remains positive, continue therapy for an additional 2-4 weeks 2
Critical Caveat: Emerging Terbinafine Resistance
This is increasingly important for recurrent cases. Recent evidence shows alarming resistance patterns, particularly in India and with Trichophyton mentagrophytes/interdigitale complex:
- 33% of isolates demonstrate high terbinafine MICs (≥1 µg/ml) 5
- Prior terbinafine exposure strongly correlates with resistance mutations (particularly F397L in the SQLE gene) 6, 5
- A recent 2023 study showed only 20-25% cure rates with standard 250 mg dosing after 4 weeks 7
When Standard Dosing May Fail
If this patient has:
- Prior terbinafine exposure
- Persistent infection despite previous treatment
- Geographic risk factors (South Asian origin or travel)
Consider alternative therapy with itraconazole (200 mg daily for 2-4 weeks), which shows better in vitro activity against resistant strains (MIC₅₀: 0.25 µg/ml) 5, 8.
Higher Dose Evidence
Doubling the dose to 500 mg daily does NOT improve outcomes. A 2023 randomized trial directly compared 250 mg vs 500 mg daily (both with topical clotrimazole) and found no significant difference in cure rates (20% vs 33.3%, P=0.82) 7. This definitively answers that higher dosing is not beneficial.
Monitoring Requirements
Given recurrent disease:
- Baseline liver function tests are mandatory before starting therapy 1
- Aim for mycological cure, not just clinical improvement 2
- Consider repeat mycology sampling until clearance is confirmed
- If no clinical improvement after 2-4 weeks, switch to second-line therapy rather than continuing ineffective treatment
Practical Algorithm
- Start: Terbinafine 250 mg daily for 4 weeks (not 2 weeks, given recurrence)
- Assess at 2 weeks: If worsening or no improvement → switch to itraconazole
- Assess at 4 weeks: If improving but not cleared → extend another 2-4 weeks
- If treatment fails: Consider resistance testing and switch to itraconazole or voriconazole 6
Do not use combination antifungal-corticosteroid products, as these contribute to resistance and treatment failure 8.